BSECompany Update6d ago · 29 Jul 2026, 03:16 am
Please find the enclosed intimation of the Company as per the captioned subject for your reference.
AstraZeneca Pharma India Ltd · 506820
✦ AI Summary
AstraZeneca Pharma India Ltd has submitted a certificate confirming compliance with Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026.
Analysis Scores
Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk0/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
AstraZeneca Pharma India Ltd - 506820 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Attachments (1)
📄pdf
Download →
9e562270-48d9-4f63-91cc-2816d9694ab6.pdf
View document text
July 29, 2026
The Manager - Listing
BSE Limited
P J Towers, Dalal Street
Fort, Mumbai - 400001
National Stock Exchange of India Ltd.
Exchange Plaza, Bandra-Kurla Complex
Bandra (E), Mumbai - 400051
Dear Sir/ Madam
Sub: Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018
We are enclosing herewith the Certificate dated July 27, 2026 issued by Integrated Registry
Management Services Private Limited, Registrar and Transfer Agents (RTA) of the Company
confirming the compliance of Regulation 74(5) of SEBI (Depositories and Participants)
Regulations, 2018 for the quarter ended June 30, 2026.
Please take the same on record.
Thanking you,
For AstraZeneca Pharma India Limited
Tanya Sanish
Company Secretary & Compliance Officer
Encl: as above
IRMSPL/ASTRA/06SS/JUN/2026 July27,2026
AstraZenecaPharmaIndiaLimited
BlockN1,12thFloor
ManyataEmbassyBusinessPark
RachenahalliOuterRingRoad
Bangalore–560045
KindAttn: CompanySecretary&ComplianceOfficer
DearMadam,
Certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants)
Sub:
Regulations,2018-Fortheperiod 01.04.2026to30.06.2026
This has reference to the Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018, we
herebyconfirmthatwehavecompliedwiththefollowingactionswithin15daysofreceiptofcertificate(s)of
securityfromthedepositoryparticipantforthepurposeofdematerialization:
1)The securities comprised in the certificate(s) Dematerialized, are listed on the stock exchange or
exchangeswheretheearlierissuedsecuritiesarelisted.
2)Mutilatedandcanceledthecertificateofsecurityforwardedbytheparticipants.
3)Substitutedthenameofthedepositoryastheregisteredownerinourrecords.
ThankingYou,
Yoursfaithfully,
ForIntegratedRegistryManagementServicesPrivateLimited
Digitally signed by S
S GIRIDHARGIRIDHAR
Date: 2026.07.27 15:32:05
+05'30'
SGiridhar
GeneralManager
Page:1/1
INTEGRATEDREGISTRYMANAGEMENTSERVICESPRIVATELTD
#30, RamanaResidency,4thCross, SampigeRoad, Malleswaram,Bangalore–560003.
PhoneNo.:08023460815to818 FaxNo.:08023460819
FixedDepositsrelatedquery EmailID:fd@integratedindia.in/SharesrelatedqueryEmailID:giri@integratedindia.in
Regd.Office: 2ndFloor,KencesTowers,No.1,RamakrishnaStreet,NorthUsmanRoad,T. Nagar,Chennai–600017
CIN:U74900TN2015PTC101466;SEBIRegnNo: INR000000544
“Appointmentofanomineeforthesharesheldbyyouisnotanoptionbutyourright!!Pleaseexerciseyourrighttonominate”